| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jonathan Sheena | Director | 2025-12-19 | 550 | $226.34 | $124.49kSell |
| Jonathan Sheena | Director | 2025-12-19 | 200 | $224.89 | $44.98kSell |
| Jonathan Sheena | Director | 2025-12-19 | 550 | $226.36 | $124.50kSell |
| Jonathan Sheena | Director | 2025-12-19 | 200 | $224.74 | $44.95kSell |
| Jonathan Sheena | Director | 2025-12-17 | 130 | $228.28 | $29.68kSell |
| Jonathan Sheena | Director | 2025-12-17 | 1,592 | $226.54 | $360.65kSell |
| Jonathan Sheena | Director | 2025-12-17 | 1,348 | $227.44 | $306.58kSell |
| Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2025-12-12 | 8,876 | $9.59 | $85.12kBuy |
| Herm Rosenman | Director | 2025-12-12 | 14,372 | $226.62 | $3.26MSell |
| Herm Rosenman | Director | 2025-12-12 | 150 | $229.10 | $34.36kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 8.98% | 12,389,033 | $2.90B | Institution |
| Price T Rowe Associates Inc | 8.66% | 11,947,415 | $2.79B | Institution |
| Jpmorgan Chase Co | 8.43% | 11,628,914 | $2.72B | Institution |
| Blackrock Inc | 7.94% | 10,964,351 | $2.56B | Institution |
| Claremont Creek Ventures L P | 4.25% | 5,864,630 | $1.37B | Insider |
| Roelof Botha | 4.06% | 5,609,069 | $1.31B | Insider |
| Sc XII Management LLC | 3.93% | 5,421,122 | $1.27B | Insider |
| Matthew Rabinowitz | 3.48% | 4,809,420 | $1.12B | Insider |
| James Healy | 3.40% | 4,697,100 | $1.10B | Insider |
| Farallon Capital Management LLC | 3.08% | 4,253,452 | $994.20M | Institution |